Washington: The US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have determined that the recommended pause regarding the use of Johnson & Johnson COVID-19 Vaccine in the US should be lifted and use of the vaccine should resume.
Health authorities in the United States on April 14 proposed a halt on the vaccine following instances of severe blood clots among a handful of the millions of Americans who received the vaccine.
The news came shortly after an expert panel recommended lifting the pause because the shots benefits exceeded possible dangers.
